Jason Douglas Wilson, Chief Financial Officer at REATA PHARMACEUTICALS INC (RETA), sold 7,000 shares at $80.00 ($560K) on 2019-01-31, disclosed to the SEC on 2019-02-04.
Open-market sale of $560k RETA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.00 | 6,135 | $491K | 87.6% |
| 2 | $80.00 | 865 | $69K | 12.4% |
| Total | $80.00 avg | 7,000 | $560K | 100% |
| Filing → |
| RETA | SELL | 2019-10-15 | $5.5M | — | Filing → |
| RETA | SELL | 2019-08-16 | $420K | — | Filing → |
| RETA | SELL | 2019-07-17 | $574K | — | Filing → |